The National Institutes of Health are funding RIT scientists to explore vesicular stomatitis virus’s (VSV) potential for treating prostate cancer. Associate Professor Maureen Ferran from the Thomas H. Gosnell School of Life Sciences secured a three-year, $451,718 Research Enhancement Award (R15) grant from the NIH to investigate prostate cancer cells’ susceptibility to the virus.